EXOZ EXOZYMES INC.
Price Chart
Executive Summary
EXOZ is conducting a dilutive public offering of common stock and warrants under its $50M shelf registration. The offering size, pricing, and net proceeds are all undisclosed placeholders. The company explicitly discloses a going-concern risk, recurring losses, and that proceeds will be insufficient to fund operations beyond the short term. The underwriter (MDB Capital) has a conflict of interest as an affiliate of the largest shareholder (47.79% pre-offering).
Actionable Insight
Expect significant downward pressure on EXOZ as the market prices in the dilutive offering and the explicit going-concern warning. The conflict-of-interest underwriting and the warrant reset provision add further bearish overhang. Monitor for the final pricing and share count in the prospectus supplement; any offering below the current market price will trigger the warrant reset clause, compounding dilution.
Key Facts
- Offering of an undisclosed number of common stock shares and warrants (2 shares + 1 warrant per unit) at an undisclosed price.
- MDB Capital Holdings LLC owns 47.79% of EXOZ pre-offering; the underwriter MDB Capital is its affiliate, creating a FINRA Rule 5121 conflict of interest.
- Company states it 'might not be able to continue as a going concern' and that net proceeds will be insufficient to fund operations beyond the short term.
- Warrants have an exercise price reset to $0.001 if the company sells stock below the offering price within one year, creating severe future dilution risk.
- Public float is $15.17M; the offering is limited to one-third of public float ($5.06M) per General Instruction I.B.6 of Form S-3.
- 8,478,992 shares outstanding pre-offering; MDB Capital Holdings holds 4,136,426 shares (47.79%).
- Lock-up: officers/directors/5% holders (excluding MDB Capital Holdings) for 6 months; company locked for 12 months with exceptions.
- No established trading market for the warrants; company does not intend to list them.
Financial Impact
Offering size is undisclosed but capped at ~$5.06M (one-third of $15.17M public float). Net proceeds are all placeholder values. Immediate substantial dilution to existing shareholders is explicitly stated.
Risk Factors
- Going-concern risk explicitly disclosed; company may not survive without additional capital.
- Immediate and substantial dilution to existing shareholders from the offering.
- Warrant exercise price reset to $0.001 could cause massive future dilution if the company sells stock at a lower price within one year.
- Conflict of interest with underwriter (MDB Capital) may lead to unfavorable pricing for existing shareholders.
- No trading market for warrants; holders may be unable to exit positions.
- Company has no planned financing arrangements beyond this offering and expects to need additional capital soon.
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001493152-26-027208 |
| Document: 0001493152-26-027208-index-headers.html | 0001493152-26-027208 |
| Document: 0001493152-26-027208-index.html | 0001493152-26-027208 |
| Document: 0001493152-26-027208.txt | 0001493152-26-027208 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 8, 2026
4d ago
|
8-K
| $9.00 awaiting T+1 | awaiting T+1 | — | $7.10 (+21.11%) |
|
Jun 8, 2026
4d ago
|
424B5
| $9.02 awaiting T+1 | awaiting T+1 | — | $7.10 (+21.29%) |
|
Jun 4, 2026
8d ago
|
424B5
| $9.35 $9.34 | ▲ +0.11% | ▼ −2.49% | $7.10 (+24.06%) |
|
May 29, 2026
14d ago
|
424B5
| $9.85 $9.67 | ▲ +1.78% | ▲ +2.04% | $7.10 (+27.88%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access